SE388420B - Sett att framstella cyklopropylmetylaminderivat - Google Patents
Sett att framstella cyklopropylmetylaminderivatInfo
- Publication number
- SE388420B SE388420B SE7317257A SE7317257A SE388420B SE 388420 B SE388420 B SE 388420B SE 7317257 A SE7317257 A SE 7317257A SE 7317257 A SE7317257 A SE 7317257A SE 388420 B SE388420 B SE 388420B
- Authority
- SE
- Sweden
- Prior art keywords
- preparing
- cyclopropylmethylamine
- derivatives
- cyclopropylmethylamine derivatives
- preparing cyclopropylmethylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5988672A GB1453703A (en) | 1972-12-28 | 1972-12-28 | Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE388420B true SE388420B (sv) | 1976-10-04 |
Family
ID=10484588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7317257A SE388420B (sv) | 1972-12-28 | 1973-12-20 | Sett att framstella cyklopropylmetylaminderivat |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US3988464A (sv) |
| JP (3) | JPS5335949B2 (sv) |
| AR (2) | AR207336A1 (sv) |
| AT (1) | AT333272B (sv) |
| BE (1) | BE809179A (sv) |
| CH (2) | CH592641A5 (sv) |
| CS (1) | CS186258B2 (sv) |
| DD (1) | DD110869A5 (sv) |
| DE (1) | DE2362754C2 (sv) |
| DK (1) | DK145574C (sv) |
| ES (1) | ES421879A1 (sv) |
| FI (1) | FI59999C (sv) |
| FR (1) | FR2212143B1 (sv) |
| GB (1) | GB1453703A (sv) |
| HU (1) | HU169273B (sv) |
| IL (3) | IL43749A (sv) |
| NL (1) | NL169472C (sv) |
| SE (1) | SE388420B (sv) |
| SU (2) | SU505348A3 (sv) |
| ZA (1) | ZA739694B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2358890A1 (fr) * | 1976-05-24 | 1978-02-17 | Science Union & Cie | Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
| FR2432513A1 (fr) * | 1977-10-24 | 1980-02-29 | Merieux Inst | Nouveaux derives de la thiazoline et leur application comme medicaments |
| DE2831600A1 (de) * | 1978-07-19 | 1980-01-31 | Boehringer Sohn Ingelheim | Neue substituierte 2-phenylamino-1, 3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben |
| FR2444673A1 (fr) * | 1978-12-20 | 1980-07-18 | Science Union & Cie | Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament |
| FR2669927B1 (fr) * | 1990-11-29 | 1994-04-08 | Adir Cie | Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DE19716237A1 (de) * | 1997-04-18 | 1998-10-22 | Basf Ag | Substituierte Benzyloxyimino-Verbindungen |
| AUPP020297A0 (en) * | 1997-11-05 | 1997-11-27 | University Of Melbourne, The | A novel receptor, and compounds which bind thereto |
| AU2003257418A1 (en) | 2002-06-19 | 2004-01-06 | Solvay Pharmaceuticals Gmbh | Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins |
| US20060283363A1 (en) * | 2005-06-07 | 2006-12-21 | Wollman Albert E | Potato Planter Improvement to Reduce Skips and Rolling |
| RU2534617C2 (ru) * | 2012-09-21 | 2014-11-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный университет" | Регулятор коллективного поведения ("чувство кворума") у бактерий |
| MX2016001714A (es) | 2013-08-09 | 2016-10-03 | Ardelyx Inc | Compuestos y metodos para inhibir el transporte de fosfato. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3626067A (en) * | 1965-07-01 | 1971-12-07 | Du Pont | Substituted oxazolines, useful as pharmaceuticals |
| NL128801C (sv) * | 1965-11-19 | |||
| DE1670753A1 (de) * | 1966-09-27 | 1970-07-16 | Bayer Ag | Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen |
| DE1670752A1 (de) * | 1966-09-27 | 1970-12-23 | Bayer Ag | Verfahren zur Herstellung von 2-Phenylamino-oxazolinen |
| DE1670751A1 (de) * | 1966-09-27 | 1970-12-23 | Bayer Ag | Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen |
-
1972
- 1972-12-28 GB GB5988672A patent/GB1453703A/en not_active Expired
-
1973
- 1973-12-04 IL IL43749A patent/IL43749A/en unknown
- 1973-12-04 IL IL49288A patent/IL49288A/en unknown
- 1973-12-17 DE DE2362754A patent/DE2362754C2/de not_active Expired
- 1973-12-18 DK DK686173A patent/DK145574C/da not_active IP Right Cessation
- 1973-12-20 SE SE7317257A patent/SE388420B/sv unknown
- 1973-12-21 NL NLAANVRAGE7317536,A patent/NL169472C/xx not_active IP Right Cessation
- 1973-12-21 CS CS7300008894A patent/CS186258B2/cs unknown
- 1973-12-24 JP JP744654A patent/JPS5335949B2/ja not_active Expired
- 1973-12-26 US US05/427,999 patent/US3988464A/en not_active Expired - Lifetime
- 1973-12-27 BE BE139340A patent/BE809179A/xx not_active IP Right Cessation
- 1973-12-27 SU SU1986164A patent/SU505348A3/ru active
- 1973-12-27 DD DD175694A patent/DD110869A5/xx unknown
- 1973-12-27 ZA ZA00739694A patent/ZA739694B/xx unknown
- 1973-12-27 FR FR7346451A patent/FR2212143B1/fr not_active Expired
- 1973-12-27 FI FI3985/73A patent/FI59999C/fi active
- 1973-12-28 ES ES421879A patent/ES421879A1/es not_active Expired
- 1973-12-28 CH CH1823573A patent/CH592641A5/xx not_active IP Right Cessation
- 1973-12-28 AT AT1089973A patent/AT333272B/de not_active IP Right Cessation
- 1973-12-28 HU HUSI1372A patent/HU169273B/hu unknown
-
1974
- 1974-01-01 AR AR256375A patent/AR207336A1/es active
- 1974-12-02 SU SU742078988A patent/SU591136A3/ru active
-
1975
- 1975-06-02 AR AR259035A patent/AR211914A1/es active
-
1976
- 1976-03-25 IL IL49288A patent/IL49288A0/xx unknown
-
1977
- 1977-01-11 CH CH1823573A patent/CH590253A5/xx not_active IP Right Cessation
- 1977-10-05 JP JP11912477A patent/JPS5359665A/ja active Granted
- 1977-10-05 JP JP11912577A patent/JPS5356664A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140556C (no) | Fremgangsmaate for fremstilling av n-fosfonometyl-glycin | |
| SE395149B (sv) | Forfarande for framstellning av dibenso-tiepinylpiperazinderivat | |
| SE398880B (sv) | Sett att framstella basiskt substituerade 3-bensoyl-bensofuranderivat | |
| SE401676B (sv) | Forfarande for framstellning av dibensofuranderivat | |
| SE388420B (sv) | Sett att framstella cyklopropylmetylaminderivat | |
| SE386173B (sv) | Sett att framstella 2-oxazolinderivat. | |
| SE385893B (sv) | Sett att framstella diakylxantin-derivat | |
| IT1002359B (it) | Metodo di preparazione di alchilati | |
| SE385707B (sv) | Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat | |
| SE399255B (sv) | Sett att framstella kinazolinonderivat | |
| SE397190B (sv) | Sett att framstella substituerade dibensocykloheptener | |
| SE400078B (sv) | Sett att framstella kinazolinonderivat | |
| SE403373B (sv) | Sett att framstella aminosubstituerade tetracykliska foreningar | |
| SE401187B (sv) | Sett att framstella delta4-3-ketosteroid-17-propiolakton | |
| RO69492A2 (ro) | Procedeu pentru prepararea perclor-metil-mercaptanului | |
| SE400281B (sv) | Sett att framstella kinazolinonderivat | |
| SE409458B (sv) | Sett att framstella 7-amino-desacetoxi-cefalosporansyra | |
| SE399411B (sv) | Sett att framstella titantetrafluorid | |
| SE404192B (sv) | Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner | |
| SE403107B (sv) | Sett att framstella 6-substituerade 3-etoxi-karbonyl hydrazino-pyridaziner | |
| SE391516B (sv) | Forfarande for framstellning av bensylaminderivat | |
| SE398644B (sv) | Sett att framstella farmaceutiskt aktiva 2,10-diklor-12-metyl-(2h-dibenso(d g))1,3)-dioxocinderivat | |
| SE396219B (sv) | Sett att framstella pyridyl-piperazinderivat | |
| SE380801B (sv) | Sett att framstella pyronoderivat av rifamyciner | |
| SE403102B (sv) | Sett att framstella indan-1-karboxylsyraderivat |